Enfusion Performance
| ENFNDelisted Stock | USD 10.76 0.00 0.00% |
The firm shows a Beta (market volatility) of -0.24, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Enfusion are expected to decrease at a much lower rate. During the bear market, Enfusion is likely to outperform the market. Enfusion right now shows a risk of 0.0%. Please confirm Enfusion potential upside, and the relationship between the information ratio and rate of daily change , to decide if Enfusion will be following its price patterns.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Enfusion has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Enfusion is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 35.6 M |
Enfusion |
Enfusion Relative Risk vs. Return Landscape
If you would invest 1,076 in Enfusion on April 17, 2025 and sell it today you would earn a total of 0.00 from holding Enfusion or generate 0.0% return on investment over 90 days. Enfusion is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Enfusion, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Enfusion Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Enfusion's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Enfusion, and traders can use it to determine the average amount a Enfusion's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ENFN |
Based on monthly moving average Enfusion is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enfusion by adding Enfusion to a well-diversified portfolio.
Enfusion Fundamentals Growth
Enfusion Stock prices reflect investors' perceptions of the future prospects and financial health of Enfusion, and Enfusion fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Enfusion Stock performance.
| Return On Equity | 0.0442 | |||
| Return On Asset | 0.0305 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 1.01 B | |||
| Shares Outstanding | 94.8 M | |||
| Price To Earning | 0.11 X | |||
| Price To Book | 13.93 X | |||
| Price To Sales | 5.06 X | |||
| Revenue | 201.61 M | |||
| EBITDA | 6.16 M | |||
| Cash And Equivalents | 56.56 M | |||
| Cash Per Share | 0.84 X | |||
| Total Debt | 20.31 M | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | 34.68 M | |||
| Earnings Per Share | 0.03 X | |||
| Total Asset | 143.26 M | |||
| Retained Earnings | (170.11 M) | |||
About Enfusion Performance
By examining Enfusion's fundamental ratios, stakeholders can obtain critical insights into Enfusion's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Enfusion is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois. Enfusion Inc operates under SoftwareApplication classification in the United States and is traded on New York Stock Exchange. It employs 892 people.Things to note about Enfusion performance evaluation
Checking the ongoing alerts about Enfusion for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Enfusion help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Enfusion is not yet fully synchronised with the market data | |
| Enfusion has a very high chance of going through financial distress in the upcoming years | |
| Over 96.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Enfusion's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Enfusion's stock is overvalued or undervalued compared to its peers.
- Examining Enfusion's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Enfusion's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Enfusion's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Enfusion's stock. These opinions can provide insight into Enfusion's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Enfusion Stock
If you are still planning to invest in Enfusion check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enfusion's history and understand the potential risks before investing.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |